Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Chul-Yong | - |
dc.contributor.author | Kim, Duk Hyoung | - |
dc.contributor.author | Son, Jeong Sang | - |
dc.contributor.author | Sung, Jin Jea | - |
dc.contributor.author | Lee, Jaehun | - |
dc.contributor.author | Bae, Sangsu | - |
dc.contributor.author | Kim, Jong-Hoon | - |
dc.contributor.author | Kim, Dong-Wook | - |
dc.contributor.author | Kim, Jin-Soo | - |
dc.date.accessioned | 2021-09-04T13:32:50Z | - |
dc.date.available | 2021-09-04T13:32:50Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2015-08-06 | - |
dc.identifier.issn | 1934-5909 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/92773 | - |
dc.description.abstract | Hemophilia A is an X-linked genetic disorder caused by mutations in the F8 gene, which encodes the blood coagulation factor VIII. Almost half of all severe hemophilia A cases result from two gross (140-kbp or 600-kbp) chromosomal inversions that involve introns 1 and 22 of the F8 gene, respectively. We derived induced pluripotent stem cells (iPSCs) from patients with these inversion genotypes and used CRISPR-Cas9 nucleases to revert these chromosomal segments back to the WT situation. We isolated inversion-corrected iPSCs with frequencies of up to 6.7% without detectable off-target mutations based on whole-genome sequencing or targeted deep sequencing. Endothelial cells differentiated from corrected iPSCs expressed the F8 gene and functionally rescued factor VIII deficiency in an otherwise lethal mouse model of hemophilia. Our results therefore provide a proof of principle for functional correction of large chromosomal rearrangements in patient-derived iPSCs and suggest potential therapeutic applications. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | CELL PRESS | - |
dc.subject | OFF-TARGET CLEAVAGE | - |
dc.subject | HUMAN-CELLS | - |
dc.subject | NUCLEASES | - |
dc.subject | CRISPR/CAS9 | - |
dc.subject | SPECIFICITY | - |
dc.subject | TALENS | - |
dc.title | Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jong-Hoon | - |
dc.identifier.doi | 10.1016/j.stem.2015.07.001 | - |
dc.identifier.scopusid | 2-s2.0-84938751866 | - |
dc.identifier.wosid | 000361878500012 | - |
dc.identifier.bibliographicCitation | CELL STEM CELL, v.17, no.2, pp.213 - 220 | - |
dc.relation.isPartOf | CELL STEM CELL | - |
dc.citation.title | CELL STEM CELL | - |
dc.citation.volume | 17 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 213 | - |
dc.citation.endPage | 220 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | OFF-TARGET CLEAVAGE | - |
dc.subject.keywordPlus | HUMAN-CELLS | - |
dc.subject.keywordPlus | NUCLEASES | - |
dc.subject.keywordPlus | CRISPR/CAS9 | - |
dc.subject.keywordPlus | SPECIFICITY | - |
dc.subject.keywordPlus | TALENS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.